TickerKhojComparison · NSE · data 2026-11-02
Gujarat Kidney & Super Speciality Ltd. vs Indraprastha Medical Corporation Limited
In plain words
Size: Indraprastha Medical Corporation Limited is about 2.2 times the market value of Gujarat Kidney & Super Speciality Ltd..
Valuation (P/E): Gujarat Kidney & Super Speciality Ltd. 82.4 vs Indraprastha Medical Corporation Limited 15.1.
Return on equity: Indraprastha Medical Corporation Limited 27.5% vs Gujarat Kidney & Super Speciality Ltd. 11.1%.
Debt to equity: Gujarat Kidney & Super Speciality Ltd. 0.12 vs Indraprastha Medical Corporation Limited 0.05.
Differences in the numbers, not a recommendation of either stock.
Side by side
| GKSL | INDRAMEDCO | |
|---|---|---|
| Price | ₹165.47 | ₹310 |
| Market cap | ₹1,289 cr | ₹2,797 cr |
| P/E | 82.4 | 15.1 |
| P/B | — | — |
| ROE | 11.1% | 27.5% |
| ROCE | 14.7% | 30.0% |
| Debt / equity | 0.12 | 0.05 |
| Operating margin | 21.3% | 15.0% |
| Dividend yield | 0.00% | 1.31% |
| Sales growth, 3 years (yearly) | — | 10.5% |
| Profit growth, 3 years (yearly) | — | 28.7% |
| 1-year return | 37.9% | -48.2% |
| Revenue, last 12 months | ₹101 cr | ₹1,524 cr |
| Net profit, last 12 months | ₹16 cr | ₹188 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹5 cr | ₹54 cr |
| Quarter profit vs a year earlier | — | +8.3% |
| Promoter holding | 71.45% | 51.00% |
| Health check | Average (5.6/10) | Strong (6.8/10) |
Common questions
Which has a higher P/E, Gujarat Kidney & Super Speciality Ltd. or Indraprastha Medical Corporation Limited?
Gujarat Kidney & Super Speciality Ltd. trades at the higher P/E (82.4 against 15.1). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Indraprastha Medical Corporation Limited (27.5% against 11.1%).
Which carries more debt?
Gujarat Kidney & Super Speciality Ltd. has the higher debt-to-equity ratio (0.12 against 0.05).